These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38792317)

  • 21. Heart failure ejection fraction class conversions: impact of biomarkers, co-morbidities, and pharmacotherapy.
    Lorenzo CJ; Conte JI; Villasmil RJ; Abdelal QK; Pierce D; Wiese-Rometsch W; Garcia-Fernandez JA
    ESC Heart Fail; 2022 Aug; 9(4):2538-2547. PubMed ID: 35570322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial.
    Tomasoni D; Davison B; Adamo M; Pagnesi M; Mebazaa A; Edwards C; Arrigo M; Barros M; Biegus J; Čelutkienė J; Čerlinskaitė-Bajorė K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Novosadova M; Pang PS; Ponikowski P; Saidu H; Sliwa K; Takagi K; Maaten JMT; Voors A; Cotter G; Metra M
    J Card Fail; 2024 Apr; 30(4):525-537. PubMed ID: 37820896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF).
    Savarese G; Kishi T; Vardeny O; Adamsson Eryd S; Bodegård J; Lund LH; Thuresson M; Bozkurt B
    JACC Heart Fail; 2023 Jan; 11(1):1-14. PubMed ID: 36202739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Desai AS; Maclean T; Blood AJ; Bosque-Hamilton J; Dunning J; Fischer C; Fera L; Smith KV; Wagholikar K; Zelle D; Gaziano T; Plutzky J; Scirica B; MacRae CA
    JAMA Cardiol; 2020 Dec; 5(12):1430-1434. PubMed ID: 32936209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Electronically Delivered Patient-Activation Tool for Intensification of Medications for Chronic Heart Failure With Reduced Ejection Fraction: The EPIC-HF Trial.
    Allen LA; Venechuk G; McIlvennan CK; Page RL; Knoepke CE; Helmkamp LJ; Khazanie P; Peterson PN; Pierce K; Harger G; Thompson JS; Dow TJ; Richards L; Huang J; Strader JR; Trinkley KE; Kao DP; Magid DJ; Buttrick PM; Matlock DD
    Circulation; 2021 Feb; 143(5):427-437. PubMed ID: 33201741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial.
    Cotter G; Deniau B; Davison B; Edwards C; Adamo M; Arrigo M; Barros M; Biegus J; Celutkiene J; Cerlinskaite-Bajore K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Metra M; Novosadova M; Pang PS; Pagnesi M; Ponikowski P; Saidu H; Sliwa K; Takagi K; Ter Maaten JM; Tomasoni D; Voors A; Mebazaa A
    JAMA Cardiol; 2024 Feb; 9(2):114-124. PubMed ID: 38150260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early left bundle branch pacing in heart failure with mildly reduced ejection fraction and left bundle branch block.
    Zeng J; He C; Zou F; Qin C; Xue S; Zhu H; Li X; Liu Z; Wei Y; Hou S; Qian Z; Wang Y; Hou X; Yao Y; Ellenbogen KA; Fan X; Zou J
    Heart Rhythm; 2023 Oct; 20(10):1436-1444. PubMed ID: 37495037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
    Savarese G; Bodegard J; Norhammar A; Sartipy P; Thuresson M; Cowie MR; Fonarow GC; Vaduganathan M; Coats AJS
    Eur J Heart Fail; 2021 Sep; 23(9):1499-1511. PubMed ID: 34132001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE-HF.
    Clephas PRD; Malgie J; Schaap J; Koudstaal S; Emans M; Linssen GCM; de Boer GA; van Heerebeek L; Borleffs CJW; Manintveld OC; van Empel V; van Wijk S; van den Heuvel M; da Fonseca C; Damman K; van Ramshorst J; van Kimmenade R; van de Ven ART; Tio RA; van Veghel D; Asselbergs FW; de Boer RA; van der Meer P; Greene SJ; Brunner-La Rocca HP; Brugts JJ
    ESC Heart Fail; 2024 Feb; 11(1):550-559. PubMed ID: 38064176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Palestine: Retrospective clinical audit study.
    Jairoun AA; Al-Hemyari SS; Shahwan M; Zyoud SH; Jairoun M
    Saudi Pharm J; 2024 Mar; 32(3):101965. PubMed ID: 38313821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial.
    Rao VN; Shah A; McDermott J; Barnes SG; Murray EM; Kelsey MD; Greene SJ; Fudim M; DeVore AD; Patel CB; Blazing MA; O'Brien C; Mentz RJ
    Circ Heart Fail; 2023 Feb; 16(2):e010158. PubMed ID: 36314130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
    JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure.
    Ter Maaten JM; Mebazaa A; Davison B; Edwards C; Adamo M; Arrigo M; Barros M; Biegus J; Čelutkienė J; Čerlinskaitė-Bajorė K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Leopold V; Novosadova M; Pagnesi M; Pang PS; Ponikowski P; Saidu H; Sliwa K; Takagi K; Tomasoni D; Metra M; Cotter G; Voors AA
    Eur J Heart Fail; 2023 Dec; 25(12):2230-2242. PubMed ID: 37905361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.
    Malgie J; Wilde MI; Clephas PRD; Emans ME; Koudstaal S; Schaap J; Mosterd A; van Ramshorst J; Wardeh AJ; van Wijk S; van den Heuvel M; Wierda E; Borleffs CJW; Saraber C; Beeres SLMA; van Kimmenade R; Jansen Klomp W; Denham R; da Fonseca CA; Klip IT; Manintveld OC; van der Boon RMA; van Ofwegen CEE; Yilmaz A; Pisters R; Linssen GCM; Faber N; van Heerebeek L; van de Swaluw JEC; Bouhuijzen LJ; Post MC; Kuijper AFM; Wu KW; van Beek EA; Hesselink T; Kleijn L; Kurvers MJM; Tio RA; Langerveld J; van Dalen BM; van Eck JWM; Handoko ML; Hermans WRM; Koornstra-Wortel HJJ; Szymanski MK; Rooker D; Tandjung K; Eijsbouts SCM; Asselbergs FW; van der Meer P; Brunner-La Rocca HP; de Boer RA; Brugts JJ
    Eur J Heart Fail; 2024 May; ():. PubMed ID: 38734980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of guideline-directed medical treatment in heart failure with mildly reduced ejection fraction.
    Zhang X; Sun Y; Zhang Y; Wang N; Sha Q; Yu S; Lv X; Ding Z; Zhang Y; Tse G; Liu Y
    ESC Heart Fail; 2023 Apr; 10(2):1035-1042. PubMed ID: 36519802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.
    Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.